Authors: Takeshi Nagata Shiro Makutani Hideo Uchida Kimihiko Kichikawa Munehiro Maeda Tetsuya Yoshioka Hiroshi Anai Hiroshi Sakaguchi Hitoshi Yoshimura
Publish Date: 2007/06/02
Volume: 30, Issue: 5, Pages: 959-
Abstract
Seventyone patients underwent stent placement and were followed until death The applicability of the spiral Zstent SZstent mainly used the initial and followup results stent placement for bilateral BCV obstruction and the value of concurrent anticancer therapy were studiedThe technical success rate was 100 the initial clinical success rate was 87 62/71 the primary clinical patency rate was 88 57/65 and the secondary clinical patency rate was 95 62/65 The obstruction rate of the stent was 12 8/65 and an additional stent was useful for relief of recurrent SVCS Survival of 57 patients in whom there was no recurrence of SVCS until death ranged from 1 week to 29 months mean 54 months and the SZstent appeared to be suitable for the treatment of the malignant obstruction of SVC Unilateral stent placement was effective for relief of SVCS with bilateral BCV obstruction Patients who received concurrent anticancer therapy survived 2 months longer than those who did notStent placement is an effective treatment for SVCS Further the utility of SZstent for SVCS an additional stent for recurrence unilateral stent for patients with bilateral BCV obstruction and anticancer therapy after stent placement were verified
Keywords: